Publish open access with Taylor & Francis Toxicology
Explore our portfolio of fully open access journals in Toxicology
Taylor & Francis Group is a leading publisher of Toxicology and Pharmacology research worldwide. We offer an outstanding portfolio of four fully open access Toxicology and Pharmacology journals. In 2018, we published 279 articles across the portfolio, and are set to publish even more in 2019. Have a browse through these titles below, and find the perfect home for your next research article.
2017 Impact Factor 3.095
Drug Delivery is a peer-reviewed, open access journal which covers the research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels.
Indexed in PubMed, Scopus, and 12 other databases.
Journal of Immunotoxicology
2017 Impact Factor of 1.465
The Journal of Immunotoxicology is an open access, peer-reviewed journal that publishes research from many subdisciplines including molecular, developmental, pulmonary, regulatory, nutritional , mechanistic, wildlife and environmental immunotoxicology, immunology, and toxicology.
Indexed in PubMed, Scopus, BIOBASE, EMBASE, the DOAJ, +5 more.
2017 Impact Factor of 1.918
Pharmaceutical Biology is an open access, peer reviewed journal, publishing high-level research on natural medicines, as well as biologically active natural products and their derivatives.
Indexed in PubMed, BIOSIS Previews, Scopus, the DOAJ + over 30 others.
Toxicology Communications publishes case reports and rapid communications in toxicology, of interest to clinical and research toxicologists, pharmacologists and forensic toxicologists.
The journal encourages veterinary case reports that can demonstrate implications for human health.
Questions about open access?
Why publish OA in our Toxicology journals?
- Increased visibility and discoverability - your research will be freely and openly available online for anyone, anywhere to read and download.
- Rigorous peer-review - each of our open access titles operates a robust peer-review process identical to those of our subscription titles.
- Indexing in a number of prestigious databases - meaning that your research will have greater impact and reach.